Valuation : HTG Molecular Diagnostics, Inc.

Market Cap 2.88K 2.48K 2.35K 2.13K 3.99K 275K 4.01K 27.89K 10.72K 140K 10.81K 10.57K 442K P/E 2021
-2.19x
P/E 2022 -0.16x
Enterprise Value -3.41M -2.94M -2.78M -2.52M -4.73M -326M -4.75M -33.03M -12.7M -166M -12.8M -12.52M -524M EV / Sales 2021
3.96x
EV / Sales 2022 0.04x
Free-Float
99.86%
Yield 2021 *
-
Yield 2022 -
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.37
5 years 0
Extreme 1.0E-6
75.96
10 years 0
Extreme 1.0E-6
2,385
Date Insider Type Main position Quantity % Market Cap. Importance
6/8/23 A Sell

Senior VP of Therapeutics

888 0.0401%
3/31/23 A Tax

Senior VP of Therapeutics

52 0.0056% -
2/2/23 A Other

Senior VP of Therapeutics

7,610 0.8264%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%0.00% - - 2
+0.87%-1.81%+20.83%-28.73% 16.73B
-1.77%+5.22%-35.05%+55.90% 1.75B
+0.08%-4.28%-28.36%+24.66% 893M
-3.05%-15.68%-58.77%-84.02% 808M
-0.05%-0.27%+63.36%-1.86% 778M
-2.56%-5.17%-38.85%-50.56% 637M
-5.26%-9.59%-43.32%-52.47% 560M
+3.41%-14.92%-44.30%-37.49% 450M
+2.02%+0.62%-7.77%-7.88% 397M
Average -10.53%-4.31%-19.14%-20.27% 2.3B
Weighted average by Cap. +0.30%-2.06%+8.33%-22.24%

Financials

2021 2022
Net sales 8.91M 7.67M 7.27M 6.59M 12.36M 851M 12.42M 86.3M 33.19M 433M 33.45M 32.72M 1.37B 6.37M 5.49M 5.19M 4.71M 8.83M 608M 8.88M 61.68M 23.72M 309M 23.91M 23.38M 978M
Net income -17.15M -14.77M -13.99M -12.68M -23.78M -1.64B -23.91M -166M -63.88M -833M -64.39M -62.98M -2.63B -21.59M -18.61M -17.62M -15.97M -29.96M -2.06B -30.11M -209M -80.46M -1.05B -81.1M -79.32M -3.32B
Net Debt -5.74M -4.94M -4.68M -4.24M -7.96M -548M -8M -55.58M -21.37M -279M -21.54M -21.07M -881M -3.41M -2.94M -2.78M -2.52M -4.73M -326M -4.76M -33.06M -12.71M -166M -12.81M -12.53M -524M
Logo HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company's Gene Expression Panels include HTG Research Use Only (RUO) Panels and HTG EdgeSeq Research Use Only (RUO) Panels, such as the HTG Transcriptome Panel, HTG EdgeSeq miRNA Whole Transcriptome Assay, HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq Precision Immuno-Oncology Panel, HTG EdgeSeq Immune Response Panel, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG EdgeSeq Mouse mRNA Tumor Response Panel, and HTG EdgeSeq DLBCL Cell of Origin Assay. The HTG EdgeSeq system provides gene expression profiling for researchers, laboratory staff, and biomarker leads in discovery, translational medicine, and oncology applications. VERI/O Laboratory Services is a molecular lab providing gene expression profiling results.
Employees
54
  1. Stock Market
  2. Stocks
  3. HTGMQ Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!